Discussion on the Main Risk Points of Supplier Management in Pharmaceutical GMP

Discussion on the Main Risk Points of Supplier Management in Pharmaceutical GMP

XUE Feng, XI Quan

PDF(2104 KB)

主办：上海医药工业研究院
　　　中国药学会
　　　中国化学制药工业协会
ISSN 1001-8255 CN 31-1243/R ZYGZEA

PDF(2104 KB)

Chinese Journal of Pharmaceuticals ›› 2021, Vol. 52 ›› Issue (01) : 131-136. DOI: 10.16522/j.cnki.cjph.2021.01.015

Pharmaceutical Management & Information

Discussion on the Main Risk Points of Supplier Management in Pharmaceutical GMP

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 52(01): 131-136 https://doi.org/10.16522/j.cnki.cjph.2021.01.015

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(2104 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉